I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| enterocyte | 3 studies | 41% ± 15% | |
| acinar cell | 3 studies | 91% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enterocyte | 3 studies | 41% ± 15% | |
| acinar cell | 3 studies | 91% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 3 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 685178.18 | 328 / 328 | 58% | 520.56 | 104 / 178 |
| intestine | 59% | 15028.66 | 570 / 966 | 41% | 122.28 | 216 / 527 |
| stomach | 64% | 130.79 | 228 / 359 | 29% | 98.45 | 84 / 286 |
| kidney | 63% | 62.64 | 56 / 89 | 9% | 1.46 | 81 / 901 |
| bladder | 57% | 37.86 | 12 / 21 | 13% | 67.12 | 67 / 504 |
| spleen | 70% | 88.75 | 169 / 241 | 0% | 0 | 0 / 0 |
| liver | 59% | 77.40 | 133 / 226 | 7% | 7.54 | 29 / 406 |
| adrenal gland | 62% | 60.94 | 160 / 258 | 1% | 0.03 | 2 / 230 |
| esophagus | 46% | 96.49 | 659 / 1445 | 14% | 80.73 | 26 / 183 |
| uterus | 57% | 70.04 | 97 / 170 | 1% | 1.08 | 4 / 459 |
| ovary | 57% | 59.08 | 103 / 180 | 0% | 0.03 | 2 / 430 |
| prostate | 50% | 57.44 | 123 / 245 | 1% | 0.03 | 3 / 502 |
| thymus | 40% | 55.82 | 263 / 653 | 0% | 0 | 0 / 605 |
| lung | 36% | 51.11 | 209 / 578 | 3% | 2.14 | 39 / 1155 |
| breast | 39% | 98.91 | 180 / 459 | 0% | 0.01 | 2 / 1118 |
| blood vessel | 36% | 175.05 | 476 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 34% | 314.15 | 409 / 1204 | 0% | 0 | 0 / 0 |
| skin | 34% | 34.56 | 607 / 1809 | 0% | 0.37 | 1 / 472 |
| heart | 31% | 53.51 | 267 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 30% | 29.48 | 280 / 929 | 0% | 0 | 0 / 0 |
| brain | 27% | 47.37 | 708 / 2642 | 1% | 0.04 | 4 / 705 |
| muscle | 25% | 25.21 | 200 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO_0043434 | Biological process | response to peptide hormone |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0070492 | Molecular function | oligosaccharide binding |
| GO_0038023 | Molecular function | signaling receptor activity |
| GO_0042834 | Molecular function | peptidoglycan binding |
| Gene name | REG1B |
| Protein name | Regenerating family member 1 beta Lithostathine-1-beta (Pancreatic stone protein 2) (PSP-2) (Regenerating islet-derived protein 1-beta) (REG-1-beta) (Regenerating protein I beta) REG1B protein (Regenerating islet-derived 1 beta (Pancreatic stone protein, pancreatic thread protein)) |
| Synonyms | hCG_40304 PSPS2 REGL |
| Description | FUNCTION: Might act as an inhibitor of spontaneous calcium carbonate precipitation. May be associated with neuronal sprouting in brain, and with brain and pancreas regeneration. |
| Accessions | Q6ICS1 ENST00000305089.8 H7BZ24 ENST00000454188.5 P48304 |
